Brenntag Acquires Alphamin
Brenntag said it completed the acquisition of all shares of specialty chemicals distributor Alphamin S.A. (Wavre, Belgium) and its subsidiary Alphamin Inc. (New Jersey). The company is focused on specialty polymers and waxes.
“With its global reach, its product portfolio and expertise, Alphamin is an attractive bolt-on acquisition for Brenntag’s existing specialty chemicals business, strengthening and expanding our existing offer to customers in the Material Science segment,” said Karsten Beckmann, member of the Board of Management of Brenntag Group and CEO Brenntag EMEA.
“Alphamin is a perfect opportunity to improve Brenntag’s technical resources, expand our presence in attractive niche markets, increase our business opportunities in promising Material Science segments, and support our global or pan-regional strategy for certain product groups such as waxes,” added Anthony Gerace, Brenntag Group’s managing director, Mergers & Acquisitions.
The business generated total sales of approximately €44.6 million in the financial year 2017/18, ended on June 30, 2018.
2026-09-09
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
Givaudan to Build New Fragrance Compounding Facility in Pedro Escobedo, Mexico
-
Unilever Sells Kate Somerville Brand to Rare Beauty Brands
-
Akzo Nobel and Axalta Announce a $25 Billion Merger Deal
-
Azelis Strengthens Partnership with SI Group, Becoming Its New Distributor of Plastic Additives
-
Clariant and FUHUA Establish Joint Venture to Co-Develop Halogen-Free Flame Retardants
-
Roche Takes Natco to Supreme Court Over Generic Risdiplam Launch in India
-
INEOS Plant Closures Deepen Europe’s Chemical Industry Crisis
-
Fracturing the Crown: BASF Antwerp’s 600-Job Cut and the Global Alarm
-
India Terminates Anti-Dumping Investigation on Chinese Siloxane Polyoxyalkylene Copolymers
-
Dow Chemical’s Freeport Plant Fire Contained; No Injuries Reported
Recommend Reading
-
BASF Raises API and Excipient Prices
-
Bayer’s Ambitious Gene & Cell Therapy Pipeline Eyes Parkinson’s, Oncology, Rare Diseases
-
Bristol Myers Squibb Launches Mavacamten (“Kopozgo”) in India for Obstructive Hypertrophic Cardiomyopathy
-
Wanhua Chemical Announces 2026 Investment Plan: RMB 27.3 Billion for Projects Plus RMB 2.22 Billion for Equity Investments
-
IMCD Acquires Dong Yang FT, Entering the Korean Beauty Sector
-
Business Society’s Market Outlook for Propylene Oxide on August 12, 2026: Price Trends Clearly Declining
-
Business Society Butadiene Daily Review: Stronger Consolidation on August 12, 2026
-
Business Society’s PTA Market Outlook for September 2, 2026: Volatile
-
In early August, the n-butanol market in Shandong, China, experienced a slight decline
-
Business Society’s PTA Market Outlook for September 1, 2026: Volatile
- Hot Searches
- 4-o-acetyldehydrozingerone sds
- kerosene prices near me today
- where to get sulfur hexafluoride
- where can i buy red phosphorus
- polyethylene terephthalate prices
- uni chem
- dapagliflozin propanediol 10 mg tablet
- lithium hydroxide
- compounded retatrutide
- aluminum sulfate purchase
- retatrutide kit
- 2876-22